Woodridge, IL, United States of America

Gen-Xian Zhao


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Gen-Xian Zhao in Antiviral Biflavanoids

Introduction

Gen-Xian Zhao is a notable inventor based in Woodridge, IL, who has made significant contributions to the field of antiviral agents. With a total of two patents to his name, Zhao's work focuses on the development of biflavanoids and their derivatives as potential treatments for various viral infections.

Latest Patents

Zhao's latest patents include the formulation of substantially purified antiviral biflavanoids such as robustaflavone, hinokiflavone, amentoflavone, agathisflavone, volkensiflavone, morelloflavone, rhusflavanone, succedaneaflavanone, GB-1a, and GB-2a. These patents also cover antiviral biflavanoid derivatives and salt forms, including robustaflavone tetrasulfate potassium salt. Furthermore, the patents disclose methods for preparing these compounds and pharmaceutical compositions that incorporate them. The biflavanoid compounds can be utilized in treating and preventing viral infections caused by agents such as influenza A and B, hepatitis B, HIV-1, herpes viruses, varicella zoster virus, and measles.

Career Highlights

Gen-Xian Zhao is currently associated with Medichem Research, Inc., where he continues to innovate in the field of antiviral research. His work has the potential to impact the treatment of viral infections significantly.

Collaborations

Zhao collaborates with esteemed colleagues, including Yuh-Meei Lin and Michael T Flavin, to advance research in antiviral agents.

Conclusion

Gen-Xian Zhao's contributions to the field of antiviral biflavanoids represent a significant advancement in the fight against viral infections. His innovative work continues to pave the way for new therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…